To test the therapeutic potential of Seldegs, experimental autoimmune encephalitis (EAE) mice with disease exacerbation due to transfer of MOG-specific antibodies derived from multiple sclerosis patients were treated with MOG-Seldegs [82]. This evidence concerns the gene MOG and multiple sclerosis.